Ranking tables

Pharma/Life Sciences: Product Liability | France

France

Rankings overview for Lawyers

Change language
English (GB)

All Lawyers profiles

Star Individuals

  1. Jacques-Antoine Robert
    Jacques-Antoine Robert
    Simmons & Simmons LLP
    Simmons & Simmons LLP | Pharma/Life Sciences: Product Liability
    2026 | Star Individuals | 20 Years Ranked

    Jacques-Antoine Robert maintains a stellar reputation for his expertise in product liability cases, including class action mandates. His impressive client roster includes leading French and international pharmaceutical companies.

1

Band 1

  1. Armand Aviges
    1
    Armand Aviges
    ADVANT Altana
    ADVANT Altana | Pharma/Life Sciences: Product Liability
    2026 | Band 1 | 6 Years Ranked

    Armand Aviges of ADVANT Altana is recognised for his expertise in product liability cases, where he acts on behalf of major pharmaceutical companies.

  2. Etienne Gouesse
    Viguié Schmidt & Associés A.A.R.P.I. | Pharma/Life Sciences: Product Liability
    2026 | Band 1
2

Band 2

  1. Alexandre Regniault
    2
    Alexandre Regniault
    Simmons & Simmons LLP
    Simmons & Simmons LLP | Pharma/Life Sciences: Product Liability
    2026 | Band 2 | 16 Years Ranked

    Alexandre Regniault is experienced in product liability cases, where he regularly represents pharmaceutical companies in civil and criminal proceedings. He additionally boasts regulatory expertise.

  2. Sylvie Welsch
    2
    Sylvie Welsch
    UGGC Avocats
    UGGC Avocats | Pharma/Life Sciences: Product Liability
    2026 | Band 2 | 1 Years Ranked

    Sylvie Welsch enters the rankings this year and advises public authorities on disputes and product liability matters.

U

Up and Coming

  1. Charles-Henri Caron
    U
    Charles-Henri Caron
    Bird & Bird
    Bird & Bird | Pharma/Life Sciences: Product Liability
    2026 | Up and Coming | 2 Years Ranked

    Charles-Henri Caron represents French and international pharmaceutical clients in product liability cases. He joined Bird & Bird in September 2025.